A phase II study of pemetrexed monotherapy in chemo-naïve Eastern Cooperative Oncology Group performance status 2 patients with EGFR wild-type or unknown advanced non-squamous non-small cell lung cancer (HANSHIN Oncology Group 002).
about
Response of brain metastasis from lung cancer patients to an oral nutraceutical product containing silibininPemetrexed monotherapy for chemo-naïve elderly (aged ≥80) patients with non-squamous non-small cell lung cancer: results from combined analysis of two single arm phase II studies (HANSHIN002 and 003).
P2860
A phase II study of pemetrexed monotherapy in chemo-naïve Eastern Cooperative Oncology Group performance status 2 patients with EGFR wild-type or unknown advanced non-squamous non-small cell lung cancer (HANSHIN Oncology Group 002).
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
A phase II study of pemetrexed ...... (HANSHIN Oncology Group 002).
@ast
A phase II study of pemetrexed ...... (HANSHIN Oncology Group 002).
@en
type
label
A phase II study of pemetrexed ...... (HANSHIN Oncology Group 002).
@ast
A phase II study of pemetrexed ...... (HANSHIN Oncology Group 002).
@en
prefLabel
A phase II study of pemetrexed ...... (HANSHIN Oncology Group 002).
@ast
A phase II study of pemetrexed ...... (HANSHIN Oncology Group 002).
@en
P2093
P2860
P1476
A phase II study of pemetrexed ...... (HANSHIN Oncology Group 002).
@en
P2093
Akihiro Nishiyama
Akito Hata
Atsushi Nakagawa
Jumpei Takeshita
Kojiro Otsuka
Kosuke Tanaka
Nobuyuki Katakami
Satoshi Morita
Shigeki Nanjo
Shunichi Negoro
P2860
P2888
P304
P356
10.1007/S00280-015-2755-2
P50
P577
2015-04-30T00:00:00Z
P6179
1037588496